Cargando…

Emergency physician perspectives on initiating buprenorphine/naloxone in the emergency department: A qualitative study

OBJECTIVES: The objective of this study was to examine the perspectives of Canadian emergency physicians on the care of patients with opioid use disorders in the emergency department (ED), in particular the real‐world facilitators to prescribing buprenorphine/naloxone (BUP) in the ED. METHODS: We co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Kathryn A., Lavergne, Karine J., Salvalaggio, Ginetta, Weber, Savannah M., Xue, Cindy Jiaxin, Kestler, Andrew, Kaczorowski, Janusz, Orkin, Aaron M., Pugh, Arlanna, Hyshka, Elaine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	General Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082712/ https://www.ncbi.nlm.nih.gov/pubmed/33969340 http://dx.doi.org/10.1002/emp2.12409

Ejemplares similares

A cross-sectional survey on buprenorphine–naloxone practice and attitudes in 22 Canadian emergency physician groups: a cross-sectional survey
por: Kestler, Andrew, et al.
Publicado: (2021)

Disparities in Emergency Department Naloxone and Buprenorphine Initiation
por: Papp, Joan, et al.
Publicado: (2023)

Patient characteristics associated with being offered take home naloxone in a busy, urban emergency department: a retrospective chart review
por: O’Brien, Daniel C., et al.
Publicado: (2019)

Comparison of Buprenorphine and Buprenorphine/naloxone in Detoxification of Opioid-dependent Men
por: Ziaaddini, Hassan, et al.
Publicado: (2018)

Reconsidering the Usefulness of Adding Naloxone to Buprenorphine
por: Blazes, Christopher K., et al.
Publicado: (2020)

Association of Formulary Prior Authorization Policies With Buprenorphine-Naloxone Prescriptions and Hospital and Emergency Department Use Among Medicare Beneficiaries
por: Mark, Tami L., et al.
Publicado: (2020)

Social service providers’ perspectives on caring for structurally vulnerable hospital patients who use drugs: a qualitative study
por: Gehring, Nicole D., et al.
Publicado: (2022)

Oxybutynin treatment for buprenorphine-naloxone-induced hyperhidrosis
por: McCormack, Lindsay, et al.
Publicado: (2021)

The Emergency Department as an Opportunity for Naloxone Distribution
por: Gunn, Alexander H., et al.
Publicado: (2018)

Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
por: Kanervo, Minna M., et al.
Publicado: (2022)

“I have such a hard time hitting myself, I thought it’d be easier”: perspectives of hospitalized patients on injecting drugs into vascular access devices
por: Brooks, Hannah L., et al.
Publicado: (2022)

Development and implementation of a physician-pharmacist collaborative practice model for provision and management of buprenorphine/naloxone
por: Mailloux, Lindsay M., et al.
Publicado: (2021)

Successful Management of Kratom Use Disorder With Buprenorphine and Naloxone
por: Arhin, Martin, et al.
Publicado: (2023)

Advancing emergency department–initiated buprenorphine
por: Huntley, Kristen, et al.
Publicado: (2021)

A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
por: Simojoki, Kaarlo, et al.
Publicado: (2008)

Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone(®)) in Spain
por: Martinez-Raga, Jose, et al.
Publicado: (2012)

Utilizing buprenorphine–naloxone to treat illicit and prescription-opioid dependence
por: Mauger, Sofie, et al.
Publicado: (2014)

Low-dose naloxone provides an abuse-deterrent effect to buprenorphine
por: Webster, Lynn R, et al.
Publicado: (2015)

Neonatal outcomes following in utero exposure to buprenorphine/naloxone or methadone
por: Gawronski, Kristen M, et al.
Publicado: (2014)

Yoga as an Adjunctive Intervention to Medication-Assisted Treatment with Buprenorphine+Naloxone
por: Lander, Laura, et al.
Publicado: (2017)

Sexual dysfunction in men on buprenorphine – naloxone-based substitution therapy
por: Mattoo, Surendra K., et al.
Publicado: (2020)

Prenatal Buprenorphine/Naloxone or Methadone Use on Neonatal Outcomes in Michigan
por: Goshgarian, Gregory, et al.
Publicado: (2022)

Microdosing and standard‐dosing take‐home buprenorphine from the emergency department: A feasibility study
por: Moe, Jessica, et al.
Publicado: (2020)

A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence during Pregnancy: Maternal and Neonatal Outcomes
por: Lund, Ingunn O., et al.
Publicado: (2013)

Patient Satisfaction with Primary Care Office-Based Buprenorphine/Naloxone Treatment
por: Barry, Declan T., et al.
Publicado: (2007)

New developments in the management of opioid dependence: focus on sublingual buprenorphine–naloxone
por: Soyka, Michael
Publicado: (2015)

Evaluation of drug-drug interaction between daclatasvir and methadone or buprenorphine/naloxone
por: Garimella, Tushar, et al.
Publicado: (2014)

Safety and Efficacy of Buprenorphine-Naloxone in Pregnancy: A Systematic Review of the Literature
por: Ordean, Alice, et al.
Publicado: (2023)

Opioid Education and Nasal Naloxone Rescue Kits in the Emergency Department
por: Dwyer, Kristin, et al.
Publicado: (2015)

Emergency-department initiated buprenorphine: Impact on quality of life
por: Carroll, Caleb, et al.
Publicado: (2023)

Impact of health system engagement on the health and well-being of people who use drugs: a realist review protocol
por: Salvalaggio, Ginetta, et al.
Publicado: (2022)

Comment on “A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence During Pregnancy: Maternal and Neonatal Outcomes”
por: Newman, Robert G., et al.
Publicado: (2013)

Outcomes among buprenorphine-naloxone primary care patients after Hurricane Sandy
por: Tofighi, Babak, et al.
Publicado: (2014)

Observational study of the safety of buprenorphine+naloxone in pregnancy in a rural and remote population
por: Jumah, Naana Afua, et al.
Publicado: (2016)

Buprenorphine/naloxone addiction in a pharmacist as a result of migraine self-treatment
por: Norton, Merrill, et al.
Publicado: (2016)

823 Evaluation of Drug-Drug Interaction between Asunaprevir and Methadone or Buprenorphine/Naloxone
por: Garimella, Tushar, et al.
Publicado: (2014)

Intravenous buprenorphine/naloxone and concomitant oral pregabalin misuse: a case report
por: Kulaksızoğlu, Burak, et al.
Publicado: (2018)

Validated Spectrophtometric Method for Simultaneous Determination of Buprenorphine and Naloxone in Pharmaceutical Dosage Forms
por: Souri, Effat, et al.
Publicado: (2017)

Therapy without a prescription: buprenorphine/naloxone diversion and the therapeutic assemblage in Taiwan
por: Chen, Jia‐shin
Publicado: (2019)

The use of buprenorphine/naloxone to treat borderline personality disorder: a case report
por: Hansen, Brenna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_83hma1i9p6o29qa4s570720hou